2023-04-01 04689593 2024-03-31 04689593 2023-04-01 2024-03-31 04689593 2023-03-31 04689593 2022-04-01 2023-03-31 04689593 uk-core:WithinOneYear 2023-03-31 04689593 uk-core:WithinOneYear 2024-03-31 04689593 uk-core:AfterOneYear 2023-03-31 04689593 uk-core:AfterOneYear 2024-03-31 04689593 uk-core:ShareCapital 2024-03-31 04689593 uk-core:ShareCapital 2023-03-31 04689593 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 04689593 uk-core:RetainedEarningsAccumulatedLosses 2023-03-31 04689593 uk-bus:Director1 2023-04-01 2024-03-31 04689593 uk-core:NetGoodwill 2023-04-01 2024-03-31 04689593 uk-core:ToolsEquipment 2023-04-01 2024-03-31 04689593 uk-core:MotorCars 2023-04-01 2024-03-31 04689593 uk-core:FurnitureFittings 2023-04-01 2024-03-31 04689593 uk-core:Goodwill 2023-03-31 04689593 uk-core:Goodwill 2024-03-31 04689593 uk-core:ToolsEquipment 2023-03-31 04689593 uk-core:FurnitureFittings 2023-03-31 04689593 uk-core:FurnitureFittings 2024-03-31 04689593 uk-core:ToolsEquipment 2024-03-31 04689593 uk-core:WithinOneYear 2024-03-31 04689593 uk-core:WithinOneYear 2023-03-31 04689593 uk-core:AfterOneYear uk-core:Secured 2024-03-31 04689593 uk-core:AfterOneYear uk-core:Secured 2023-03-31 iso4217:GBP xbrli:pure 04689593 uk-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04689593 uk-bus:FRS102 2023-04-01 2024-03-31 04689593 uk-bus:FilletedAccounts 2023-04-01 2024-03-31 04689593 uk-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Collins Therapeutic Consulting Limited
Registered Number:04689593
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 March 2024
Collins Therapeutic Consulting Limited
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
04689593
As at 31 March 2024
Collins Therapeutic Consulting Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
2,473
2,424
3
2,473
2,424
Current assets
Trade and other receivables
10,383
293
4
Financial assets
321,616
313,359
5
16,030
Cash and cash equivalents
17,107
330,759
348,029
Trade and other payables: amounts falling due within one year
(8,143)
(6,829)
6
339,886
323,930
Net current assets
Total assets less current liabilities
326,403
342,310
Trade and other payables: amounts falling due after more than
one year
(7,180)
(4,040)
7
322,363
Net assets
335,130
Capital and reserves
Called up share capital
2
2
Retained earnings
322,361
335,128
322,363
335,130
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mrs Caroline Anne Collins Director
These financial statements were approved and authorised for issue by the Board on 06 October 2024 and were signed by:
The notes form part of these financial statements
1 of 4
4
For the year ended 31 March 2024
Collins Therapeutic Consulting Limited
Notes to the Financial Statements
Statutory Information
Collins Therapeutic Consulting Limited is a private limited company, limited by shares, domiciled in England and Wales,
registration number 04689593.
Principal place of business:
Acer Cottage
Park Road
Chipping Campden
Gloucestershire
GL55 6EA
Registered address:
40 High Street
Pershore
Worcs
WR10 1DP
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain
assets.
Revenue recognition
Turnover represents amounts receivable for services. Amounts receivable for services performed over time are based upon the stage of completion of the services performed.
Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2004, is being amortised evenly over its estimated useful life of 10 years.
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
25% Straight line
Computer equipment
25% Reducing balance
Motor vehicles
25% Straight line
Fixtures and fittings
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable.
2 of 4
5
For the year ended 31 March 2024
Collins Therapeutic Consulting Limited
Notes to the Financial Statements Continued
2. Intangible fixed assets
Goodwill
Cost or valuation
£
At 01 April 2023
20,000
At 31 March 2024
20,000
Amortisation
At 01 April 2023
20,000
At 31 March 2024
20,000
Net book value
At 31 March 2024
-
At 31 March 2023
-
3. Property, plant and equipment
Total
Computer
equipment
Fixtures and
fittings
£
£
£
Cost or valuation
At 01 April 2023
17,553
16,767
786
875
875
-
Additions
At 31 March 2024
786
17,642
18,428
Provision for depreciation and impairment
At 01 April 2023
15,129
14,637
492
Charge for year
826
532
294
At 31 March 2024
15,955
15,169
786
At 31 March 2024
Net book value
-
2,473
2,473
At 31 March 2023
294
2,130
2,424
4. Trade and other receivables
2023
2024
£
£
Trade debtors
-
7,278
Other debtors
293
3,105
10,383
293
3 of 4
6
For the year ended 31 March 2024
Collins Therapeutic Consulting Limited
Notes to the Financial Statements Continued
5. Financial instruments at fair value
2023
2024
£
£
Other investments
313,359
321,616
6. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Bank loans and overdraft
3,240
3,240
Trade creditors
476
1,903
Other creditors
3,113
3,000
6,829
8,143
7. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft
4,040
7,180
8. Average number of persons employed
During the year the average number of employees was 3.
9. Transition to FRS 102
The principal accounting polices applied in the preparation of the financial statements are set out above. These policies have
been consistently applied to all the years presented, unless otherwise stated. No changes have arisen as a result of the
transition to Section 1A of Financial Reporting Standard 102.
4 of 4